pyrimidin-2-one beta-ribofuranoside has been researched along with B-Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, JN; Flesner, BK; Kumar, SR | 1 |
1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and B-Cell Leukemia
| Article | Year |
|---|---|
6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cytidine; DNA-Cytosine Methylases; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Down-Regulation; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Thioguanine | 2014 |